Anti-NUCB2/ HEL-S-109/ NEFA monoclonal antibody

Anti-NUCB2/ HEL-S-109/ NEFA antibody for FACS & in-vivo assay

Target products collectionGo to NUCB2/NUCB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0915-Ab-1/ GM-Tg-hg-MP0915-Ab-2Anti-Human NUCB2 monoclonal antibodyHuman
GM-Tg-rg-MP0915-Ab-1/ GM-Tg-rg-MP0915-Ab-2Anti-Rat NUCB2 monoclonal antibodyRat
GM-Tg-mg-MP0915-Ab-1/ GM-Tg-mg-MP0915-Ab-2Anti-Mouse NUCB2 monoclonal antibodyMouse
GM-Tg-cynog-MP0915-Ab-1/ GM-Tg-cynog-MP0915-Ab-2Anti-Cynomolgus/ Rhesus macaque NUCB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0915-Ab-1/ GM-Tg-felg-MP0915-Ab-2Anti-Feline NUCB2 monoclonal antibodyFeline
GM-Tg-cang-MP0915-Ab-1/ GM-Tg-cang-MP0915-Ab-2Anti-Canine NUCB2 monoclonal antibodyCanine
GM-Tg-bovg-MP0915-Ab-1/ GM-Tg-bovg-MP0915-Ab-2Anti-Bovine NUCB2 monoclonal antibodyBovine
GM-Tg-equg-MP0915-Ab-1/ GM-Tg-equg-MP0915-Ab-2Anti-Equine NUCB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0915-Ab-1/ GM-Tg-hg-MP0915-Ab-2; GM-Tg-rg-MP0915-Ab-1/ GM-Tg-rg-MP0915-Ab-2;
GM-Tg-mg-MP0915-Ab-1/ GM-Tg-mg-MP0915-Ab-2; GM-Tg-cynog-MP0915-Ab-1/ GM-Tg-cynog-MP0915-Ab-2;
GM-Tg-felg-MP0915-Ab-1/ GM-Tg-felg-MP0915-Ab-2; GM-Tg-cang-MP0915-Ab-1/ GM-Tg-cang-MP0915-Ab-2;
GM-Tg-bovg-MP0915-Ab-1/ GM-Tg-bovg-MP0915-Ab-2; GM-Tg-equg-MP0915-Ab-1/ GM-Tg-equg-MP0915-Ab-2
Products NameAnti-NUCB2 monoclonal antibody
Formatmab
Target NameNUCB2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NUCB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NUCB2/ HEL-S-109/ NEFA VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004246mouse Nucb2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004246mouse Nucb2 Lentivirus particle


    Target information

    Target IDGM-MP0915
    Target NameNUCB2
    Gene ID4925,53322,59295,697084,476876,101096763,509003,100056479
    Gene Symbol and SynonymsCalnuc,HEL-S-109,NEFA,Nesfatin-1,NUCB2,p54
    Uniprot AccessionP80303,Q9JI85
    Uniprot Entry NameNUCB2_HUMAN,NUCB2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000070081
    Target ClassificationN/A

    The target: NUCB2, gene name: NUCB2, also named as HEL-S-109, NEFA. This gene encodes a protein with a suggested role in calcium level maintenance, eating regulation in the hypothalamus, and release of tumor necrosis factor from vascular endothelial cells. This protein binds calcium and has EF-folding domains. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.